Kevin Currie
- Organic Chemistry top 5%
- Synthesis of Tetrazole Derivatives 1
- Click Chemistry and Applications 1
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
- Toxicology top 10%
-
- Chronic Myeloid Leukemia Treatments 3
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Mast cells and histamine 3
-
- Chemical Synthesis and Analysis 1
-
- Tuberculosis Research and Epidemiology 1
- Co-authors
- James W. DarrowRobert DesimoneDouglas A. PippinScott A. MitchellPatrícia MaciejewskiJulie A. Di PaoloJeffrey E. KropfPeter Blomgren
- Cited by
- Organic ChemistryGeneticsToxicology
- Journals
- Journal of Medicinal Chemistry (1 paper)Annals of the Rheumatic Diseases (1 paper)Oncotarget (1 paper)
- Partner nations
- United States
In The Last Decade
Kevin Currie
9 papers receiving 738 citations
Peers
Comparison fields: 5 of 77
- Organic Chemistry 460
- Genetics 85
- Toxicology 23
- Hematology 57
- Pharmacology 72
Countries citing papers authored by Kevin Currie
This map shows the geographic impact of Kevin Currie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Currie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Currie more than expected).
Fields of papers citing papers by Kevin Currie
This network shows the impact of papers produced by Kevin Currie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Currie. The network helps show where Kevin Currie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kevin Currie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 10 | |
| 2 | 2019 | 12 | |
| 3 | 2018 | 10 | |
| 4 | 2016 | 1 | |
| 5 | 2014 | 131 | |
| 6 | 2014 | 55 | |
| 7 | 2009 | 28 | |
| 8 | 2007 | 2 | |
| 9 | 2004 | 495 | |
| 10 | 1995 | 11 |
About Kevin Currie
Kevin Currie is a scholar working on Genetics, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 755 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Mast cells and histamine (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Synthesis of Tetrazole Derivatives (1 paper), Chemical Synthesis and Analysis (1 paper), Tuberculosis Research and Epidemiology (1 paper) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Organic Chemistry (460 citations), Genetics (85 citations) and Toxicology (23 citations). Kevin Currie has collaborated with scholars based in United States. Frequent co-authors include James W. Darrow, Robert Desimone, Douglas A. Pippin, Scott A. Mitchell, Patrícia Maciejewski, Julie A. Di Paolo, Jeffrey E. Kropf, Peter Blomgren, J. Andrew Whitney and Zhongdong Zhao. Their work appears in journals such as Journal of Medicinal Chemistry, Annals of the Rheumatic Diseases and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.